Vir Biotechnology Inc. (VIR) Misses Q1 EPS by 19c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Vir Biotechnology Inc. (VIR) Misses Q1 EPS by 19c

Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results

May 4, 2023 4:05 PM EDT

Multiple data readouts anticipated in 2023 from ongoing Phase 2 programsin hepatitis B and D, and influenza

Industry veteran Dr. Marianne De Backer assumes CEO position prepared to lead Company through next phase of growth

 $2.3 billion in cash, cash equivalents, and investments as of March 31, 2023 

SAN FRANCISCO, May 04, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the first quarter ended March 31, 2023.

Vir is at an exciting inflection... More